Oct 10 (Reuters) – Johnson & Johnson is in discussions to buy Protagonist Therapeutics, the Wall Street Journal reported on Friday, citing people familiar with the matter. Shares of Protagonist were up 9.4% in morning trade. (Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D'Silva)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Jonathan Stempel (Reuters) -A Delaware judge said former Activision Blizzard officials including Chief Executive…
(Adds comments, background in paragraphs 3-13) * Musalem open to 'potential' rate cut as insurance…
VIDEO SHOWS: SERBIAN AND ALBANIAN NATIONAL SOCCER TEAMS TRAINING / PRESS CONFERENCES WITH EACH TEAM…
WASHINGTON, Oct 10 (Reuters) - The U.S. Department of Education said on Friday it would…
By Jarrett Renshaw WASHINGTON (Reuters) -President Donald Trump is expected to make an announcement on…
By David Shepardson WASHINGTON (Reuters) -The chair of the Federal Communications Commission said on Friday…